Stocks/Funds/CIK 2103725

AIHC Capital Management Ltd

concentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 2103725
Assets
$120M
Holdings
5
Lifetime alpha vs market
+158.20% annual
Average hold time
0.5 yr
median 0.5 yr

Quarterly history

Cum return +21% vs S&P -4% · α +26% lifetimeAUM $120M · peak $120MFlow $-10M (-9%)2025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
when a holding falls −10%+
Middle response
-48.60%
baseline attrition
Rally response
-7.91%
trims into rallies
when a holding rises +10%+

Top positions · 5

Ticker$ value% portYoYHold time
RVMDRevolution Medicines, In$81M67.4%0.5 yr
ORICORIC Pharmaceuticals, In$31M26.0%0.3 yr
IMABI-Mab$6M4.7%0.5 yr
COGTCogent Biosciences, Inc.$2M1.7%0.5 yr
KRROKorro Bio, Inc.$0M0.3%0.5 yr

Portfolio composition (YoY)

Industry mix
Biotechnology100.0%$120M
Country
US100.0%
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 2

IMAB I-Mab+$0M
ORIC ORIC Pharmaceuticals, Inc.new+$31M

Top sells this quarter · 4

PTGX Protagonist Therapeutics, Inc.exit$20M
AVBP ArriVent BioPharma, Inc. Commoexit$15M
RVMD Revolution Medicines, Inc.$72M
COGT Cogent Biosciences, Inc.$2M

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$120M5+21.22%-4.37%+25.59%-0.01B
2025-12-31$107M6